SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-763751
Filing Date
2016-11-09
Accepted
2016-11-09 08:02:47
Documents
41
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d447194d10q.htm 10-Q 192996
2 EX-10.1 d447194dex101.htm EX-10.1 1259282
3 EX-10.2 d447194dex102.htm EX-10.2 102796
4 EX-31.1 d447194dex311.htm EX-31.1 9099
5 EX-31.2 d447194dex312.htm EX-31.2 8634
6 EX-32.1 d447194dex321.htm EX-32.1 4644
  Complete submission text file 0001193125-16-763751.txt   3148953

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT meip-20160930.xml EX-101.INS 194079
8 XBRL TAXONOMY EXTENSION SCHEMA meip-20160930.xsd EX-101.SCH 25747
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE meip-20160930_cal.xml EX-101.CAL 28963
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE meip-20160930_def.xml EX-101.DEF 163617
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE meip-20160930_lab.xml EX-101.LAB 245213
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE meip-20160930_pre.xml EX-101.PRE 188273
Mailing Address 11975 EL CAMINO REAL SUITE 101 SAN DIEGO CA 92130
Business Address 11975 EL CAMINO REAL SUITE 101 SAN DIEGO CA 92130 858-792-6300
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-50484 | Film No.: 161982846
SIC: 2834 Pharmaceutical Preparations